EUVIMEDEUVIMED entdecken
Studienprotokoll

Global Assessment of Predictive Biomarkers in Malian BCLC Stage C Hepatocellular Carcinoma Patients under Mono or Combination Immune Checkpoint Inhibitors Treatment: A Proposed Research Protocol

Keita Kaly, Abdoulaye K, Diawara Abdoulaye, Alou AK, Bathily Moussa, Dembélé AK, Sidibé Mariam, Coulibay Aissata, Kamaté Bakarou, Bougadari TC, Wélé Mamadou, Traoré Kassim und 5 weitere

International Journal of Research in Oncology · 2023

DOI: 10.33425/2833-0390.1012 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift International Journal of Research in Oncology, 2023. Verfasst von Keita Kaly und 16 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background: According to the Barcelona Clinic Liver Cancer (BCLC) staging system, only the advanced stage (stage C) hepatocellular carcinoma (HCC) patient is eligible for systemic treatments. In addition to sorafenib and lenvatinib that represent the standard-of-care options in the first-line treatment, the multikinase inhibitors regorafenib and cabozantinib or ramucirumab, the anti-vascular-endothelial growth factor-2 (VEGF-R2) in the second-line setting but their poor tolerability have brought out the need for new therapeutic strategies, the immune checkpoint inhibitors (ICIs) might represent the most important novelty and the future perspective also in the field of HCC. Therefore, the need to identify predictive biomarkers to select those patients who might actually benefit from ICIs-based treatment is urgently a challenge. Our central hypothesis is that the global assessment of predictive biomarkers could help patient-specific choices for ICIs treatment by developing simplified therapeutic algorithms and novel prognostic index for efficient HCC management. The primary aim of this work will be to globally assess predictive biomarkers in Malian patients with BCLC stage C HCC undergoing treatment with ICIs in mono or in combination.

Zitieren

APA

Kaly, K., K, A., Abdoulaye, D., AK, A., Moussa, B., AK, D., Mariam, S., Aissata, C., Bakarou, K., TC, B., Mamadou, W., Kassim, T., Djénéba, D., O, S., Ak, S., AK, T., & Mahamadou, D. (2023). Global Assessment of Predictive Biomarkers in Malian BCLC Stage C Hepatocellular Carcinoma Patients under Mono or Combination Immune Checkpoint Inhibitors Treatment: A Proposed Research Protocol. International Journal of Research in Oncology. https://doi.org/10.33425/2833-0390.1012

Vancouver

Kaly K, K A, Abdoulaye D, AK A, Moussa B, AK D, et al. Global Assessment of Predictive Biomarkers in Malian BCLC Stage C Hepatocellular Carcinoma Patients under Mono or Combination Immune Checkpoint Inhibitors Treatment: A Proposed Research Protocol. International Journal of Research in Oncology. 2023. doi:10.33425/2833-0390.1012

BibTeX
@article{Kaly2023,
  author = {Kaly, Keita and K, Abdoulaye and Abdoulaye, Diawara and AK, Alou and Moussa, Bathily and AK, Dembélé and Mariam, Sidibé and Aissata, Coulibay and Bakarou, Kamaté and TC, Bougadari and Mamadou, Wélé and Kassim, Traoré and Djénéba, Dabitao and O, Samassekou and Ak, Soukho and AK, Traoré and Mahamadou, Diakité},
  title = {Global Assessment of Predictive Biomarkers in Malian BCLC Stage C Hepatocellular Carcinoma Patients under Mono or Combination Immune Checkpoint Inhibitors Treatment: A Proposed Research Protocol},
  journal = {International Journal of Research in Oncology},
  year = {2023},
  doi = {10.33425/2833-0390.1012}
}
Kostenlos starten →